Mariana Oncology
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- $250M
Investors
- 8
About Mariana Oncology
, trading as Curie, is a biotechnology company that provides radiopharmaceuticals for the treatment of tumors. In September 2023, Mariana Oncology, Inc. Curie Therapeutics, Inc. develops integrated radiopharmaceuticals that are used to diagnose solid cancers and deliver radiation directly to disease sites. Curie ligands are designed to allow deeper, more homogeneous tumor distribution as well as rapid systemic clearance. Curie’s macrocyclic peptide-based drug targets extracellular domains. Curie uses both alpha and beta-emitting radionuclides to address significant therapeutic needs in solid tumor biology.
Who invested in Mariana Oncology
8 investors across 2 rounds
See all investors in Mariana Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mariana Oncology
Who invested in Mariana Oncology?
Mariana Oncology has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mariana Oncology raised?
Mariana Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mariana Oncology last raise money?
Mariana Oncology's most recent round on record is a Series B, in Sep 2023.
What does Mariana Oncology do?
, trading as Curie, is a biotechnology company that provides radiopharmaceuticals for the treatment of tumors.
Where is Mariana Oncology headquartered?
Mariana Oncology is headquartered in Watertown, US.
Which VCs invest in companies like Mariana Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mariana Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Mariana Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.